Peri-Procedural Infarction in Angioplasty vs. Surgery in the Left Main Coronary Artery

According to the EXCEL trial, peri-procedural infarction was more common after left main coronary artery surgery compared with angioplasty, and it was strongly associated with increased 3-year mortality after controlling all possible confounding variables. This increased mortality was only present in extensive infarctions with an increase in CK-MB ≥10×.

The EXCEL trial seems to want to challenge the SYNTAX trial as far as the number of sub-studies goes. Month after month we find a new published article derived from EXCEL trial data.

This particular work examined the 3-year rates of mortality among patients with and without peri-procedural infarction in a setting of left main coronary artery revascularization, who were randomized to angioplasty with an everolimus-eluting stent or surgery in the large-scale, multicenter, prospective, randomized EXCEL trial.

Per protocol, identical criteria were specified to define peri-procedural infarction for both strategies: CK-MB elevation >10× the upper reference limit within 72 h after the procedure, or >5× with new Q-waves, angiographic vessel occlusion, or loss of myocardial mass on imaging.


Read also: Next-Day Discharge after TAVR: Equally Safe for All Prosthesis?


The sub-study included a total of 1858 patients; the number of patients who met the criteria for peri-procedural infarction was 34 out of 935 (3.6%) patients in the angioplasty group and 56 out of 923 (6.1%) patients in the surgery group (odds ratio: 0.61; 95% confidence interval [CI]: 0.40–0.93; p = 0.02).

Periprocedural infarction was associated with anatomical complexity (SYNTAX score), chronic obstructive pulmonary disease, cross-clamp duration and total procedure duration, and not using antegrade cardioplegia.

Peri-procedural infarction almost tripled the 3-year mortality rates (hazard ratio [HR]: 2.63; 95% CI: 1.19-5.81; p = 0.02). Such effect was consistent for both revascularization strategies.


Read also: Functional Assessment of Lesions: Advances with MRI.


Peak post-procedure CK-MB ≥10× was clearly associated with mortality, whereas lesser degrees did not change the prognosis.

Conclusion

In the EXCEL trial, peri-procedural infarction was more common after surgery compared with angioplasty as treatment in the left main coronary artery, and it was strongly associated with increased 3-year mortality. Only extensive infarctions (CK-MB ≥10×) had an impact on prognosis.

Original title: Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for leftmain disease: an analysis from the EXCEL trial.

Reference: Ori Ben-Yehuda et al. European Heart Journal (2019) 0, 1–12.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...